Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.
Aerpio Pharmaceuticals shares are trading higher after HC Wainwright & Co. upgraded the company's stock from Neutral to Buy and announced a $22 price target.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.